A retrosynthetic biology approach to therapeutics: from conception to delivery.

De novo biosynthetic pathways are designed, assembled and optimized to produce high-value compounds such as drugs and chemical building blocks from renewable resources. Microorganisms are used as synthetic platforms of systems biology where biochemical pathways are engineered into the host metabolic network. Retrosynthetic biology offers a creative pathway design concept that has gained interest because of its potential to identify novel metabolic ways for therapeutic production. Retrosynthetic biology uses the backward search of retrosynthetic analysis to devise and optimize tailor-made pathways. The retrosynthetic process can be seamlessly integrated into a complete circuitry system for therapeutic applications where production, sensing and delivery act as constitutive interconnecting parts. The aim of this review is to highlight recent efforts toward synthetic design for therapeutic development.

[1]  J. March,et al.  Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes , 2008, Applied and Environmental Microbiology.

[2]  Jens Nielsen,et al.  Synergies between synthetic biology and metabolic engineering , 2011, Nature Biotechnology.

[3]  F. Sato,et al.  A bacterial platform for fermentative production of plant alkaloids , 2011, Nature communications.

[4]  Radhakrishnan Mahadevan,et al.  In silico characterization of microbial electrosynthesis for metabolic engineering of biochemicals , 2011, Microbial cell factories.

[5]  S. Lee,et al.  Systems Metabolic Engineering for Chemicals and Materials , 2010 .

[6]  Li-hua Yu,et al.  Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm , 2011, Antimicrobial Agents and Chemotherapy.

[7]  Christina D Smolke,et al.  Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins , 2010, Science.

[8]  A. Jetten,et al.  Molecular mechanisms involved in farnesol-induced apoptosis. , 2010, Cancer letters.

[9]  Rosário Oliveira,et al.  Effect of Farnesol on Structure and Composition of Staphylococcus epidermidis Biofilm Matrix , 2011, Current Microbiology.

[10]  Pablo Carbonell,et al.  Engineering antibiotic production and overcoming bacterial resistance , 2011, Biotechnology journal.

[11]  Sang Yup Lee,et al.  Construction and optimization of synthetic pathways in metabolic engineering. , 2010, Current opinion in microbiology.

[12]  Martin Fussenegger,et al.  Self-sufficient control of urate homeostasis in mice by a synthetic circuit , 2010, Nature Biotechnology.

[13]  Hong Zhang,et al.  Synthetic circuits, devices and modules , 2010, Protein & Cell.

[14]  Simon R. Carding,et al.  Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf‐&bgr;1 under the control of dietary xylan , 2011, Inflammatory bowel diseases.

[15]  Christopher A. Voigt,et al.  Prokaryotic gene clusters: A rich toolbox for synthetic biology , 2010, Biotechnology journal.

[16]  Sunwon Park,et al.  Prediction of novel synthetic pathways for the production of desired chemicals , 2010, BMC Systems Biology.

[17]  Christina D Smolke,et al.  Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems , 2010, Proceedings of the National Academy of Sciences.

[18]  T Chris Aurand,et al.  Synthetic signaling networks for therapeutic applications. , 2012, Current opinion in biotechnology.

[19]  Uwe T Bornscheuer,et al.  Finding better protein engineering strategies. , 2009, Nature chemical biology.

[20]  W. Bentley,et al.  Engineered biological nanofactories trigger quorum sensing response in targeted bacteria. , 2010, Nature nanotechnology.

[21]  Martin Fussenegger,et al.  Molecular diversity--the toolbox for synthetic gene switches and networks. , 2011, Current opinion in chemical biology.

[22]  Kai Sundmacher,et al.  Designing Biological Systems: Systems Engineering meets Synthetic Biology , 2012 .

[23]  Bernard Coulie,et al.  AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. , 2010, Oral oncology.

[24]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[25]  Pablo Carbonell,et al.  Enumerating metabolic pathways for the production of heterologous target chemicals in chassis organisms , 2012, BMC Systems Biology.

[26]  J. Reed,et al.  Large-Scale Bi-Level Strain Design Approaches and Mixed-Integer Programming Solution Techniques , 2011, PloS one.

[27]  Martin Fussenegger,et al.  Emerging biomedical applications of synthetic biology , 2011, Nature Reviews Genetics.

[28]  Pablo Carbonell,et al.  A retrosynthetic biology approach to metabolic pathway design for therapeutic production , 2011, BMC Systems Biology.

[29]  Peter D. Karp,et al.  Machine learning methods for metabolic pathway prediction , 2010 .

[30]  Wilfried Weber,et al.  Therapeutic synthetic gene networks. , 2012, Current opinion in biotechnology.

[31]  Anthony P. F. Cook,et al.  Computer‐aided synthesis design: 40 years on , 2012 .

[32]  G. Stephanopoulos,et al.  Relative potential of biosynthetic pathways for biofuels and bio-based products , 2011, Nature Biotechnology.

[33]  Timothy K Lu,et al.  Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy , 2009, Proceedings of the National Academy of Sciences.

[34]  Jay D Keasling,et al.  Heterologous production of polyketides by modular type I polyketide synthases in Escherichia coli. , 2012, Current opinion in biotechnology.

[35]  Chueh Loo Poh,et al.  Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen , 2011, Molecular systems biology.

[36]  J. Collins,et al.  Synthetic Biology Moving into the Clinic , 2011, Science.

[37]  John C March,et al.  Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model , 2010, Proceedings of the National Academy of Sciences.

[38]  Jay D Keasling,et al.  Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway , 2010, Biotechnology and bioengineering.

[39]  N. Kelleher,et al.  A Proteomics Approach to Discovery of Natural Products and Their Biosynthetic Pathways , 2009, Nature Biotechnology.

[40]  L. Nissim,et al.  A tunable dual-promoter integrator for targeting of cancer cells , 2010, Molecular systems biology.

[41]  Elizabeth Brunk,et al.  Integrating computational methods to retrofit enzymes to synthetic pathways , 2012, Biotechnology and bioengineering.

[42]  Wei Cheng,et al.  Salmonella‐mediated tumor‐targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model , 2012, Cancer science.

[43]  Costas D. Maranas,et al.  OptForce: An Optimization Procedure for Identifying All Genetic Manipulations Leading to Targeted Overproductions , 2010, PLoS Comput. Biol..

[44]  Martin Fussenegger,et al.  A designer network coordinating bovine artificial insemination by ovulation-triggered release of implanted sperms. , 2011, Journal of Controlled Release.

[45]  B. Bachmann.  Biosynthesis: is it time to go retro? , 2010, Nature chemical biology.

[46]  E. Santero,et al.  In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit , 2007, Nature Methods.

[47]  Andrea Crisanti,et al.  A synthetic homing endonuclease-based gene drive system in the human malaria mosquito , 2011, Nature.

[48]  Meghdad Hajimorad,et al.  BglBrick vectors and datasheets: A synthetic biology platform for gene expression , 2011, Journal of biological engineering.

[49]  Jay D. Keasling,et al.  Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin , 2012, Proceedings of the National Academy of Sciences.

[50]  J. Keasling.  Synthetic biology and the development of tools for metabolic engineering. , 2012, Metabolic engineering.

[51]  W. Bentley,et al.  Biological nanofactories target and activate epithelial cell surfaces for modulating bacterial quorum sensing and interspecies signaling. , 2010, ACS Nano.

[52]  G. Stephanopoulos,et al.  Optimization of a heterologous pathway for the production of flavonoids from glucose. , 2011, Metabolic engineering.

[53]  Ryan T Gill,et al.  Synthetic biology: new strategies for directing design. , 2012, Metabolic engineering.

[54]  A. James,et al.  Genetic elimination of dengue vector mosquitoes , 2011, Proceedings of the National Academy of Sciences.

[55]  Steffen Klamt,et al.  CASOP: a computational approach for strain optimization aiming at high productivity. , 2010, Journal of biotechnology.

[56]  Pablo Carbonell,et al.  Compound toxicity screening and structure-activity relationship modeling in Escherichia coli. , 2012, Biotechnology and bioengineering.